Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 174
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Turk J Med Sci ; 50(4): 706-712, 2020 06 23.
Artículo en Inglés | MEDLINE | ID: mdl-32041384

RESUMEN

Background/aim: To investigate the correlation between the Glasgow-Blatchford score, shock index, and Forrest classification in patients with peptic ulcer bleeding (PUB). Materials and methods: A total of 955 patients with PUB were assessed using the Glasgow-Blatchford score and shock index, as well as the Forrest classification based on their gastroscopy results. The correlation between the Glasgow-Blatchford score and shock index was determined using scatter plot analysis, and the correlation between the Glasgow-Blatchford score or shock index and Forrest classification was determined using Spearman's analysis. Results: Both the Glasgow-Blatchford score and shock index showed the highest values in patients with Forrest class IIa. The Glasgow- Blatchford score was significantly higher than patients with Forrest class Ib/IIc/III (P < 0.05), and the shock index was significantly higher than patients with Forrest class Ib/IIb/III (P < 0.05). A positive correlation was observed between the Glasgow-Blatchford score and shock index, at r = 0.427 (P < 0.001). A negative correlation was observed between the Glasgow-Blatchford score and Forrest classification, at r = ­0.111 (P < 0.01), and between the shock index and Forrest classification, at r = ­0.138 (P < 0.01). Conclusion: A moderate correlation was observed between the Glasgow-Blatchford score and shock index in patients with PUB, and the correlation between the Forrest classification and Glasgow-Blatchford score or shock index was relatively low.


Asunto(s)
Gastroscopía/métodos , Úlcera Péptica Hemorrágica/diagnóstico , Úlcera Péptica Hemorrágica/fisiopatología , China , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Medición de Riesgo , Índice de Severidad de la Enfermedad
2.
Khirurgiia (Mosk) ; (3): 4-10, 2017.
Artículo en Ruso | MEDLINE | ID: mdl-28374707

RESUMEN

AIM: To explore microcirculatory changes within the first 48 hours after admission, to compare them with clinical manifestations of bleeding and to define the dependence of recurrent bleeding from the therapy. MATERIAL AND METHODS: The study included 108 patients with ulcerative gastroduodenal bleeding who were treated at the Clinical Hospital #71 for the period 2012-2014. There were 80 (74.1%) men and 28 (25.9%) women. Age ranged 20-87 years (mean 54.4±16.8 years). Patients younger than 45 years were predominant (33.4%). J. Forrest classification (1974) was used in endoscopic characterization of bleeding. Roccal Prognostic Scale for gastroduodenal bleeding was applied in all patients at admission to assess the risk of possible recurrence. Patients were divided into 2 groups. Group 1 included 53 (49.1%) patients without recurrent bleeding; group 2-55 (50.1%) patients who had recurrent bleeding within the first two days of treatment. RESULTS: Investigation of microcirculation showed the role of vegetative component including blood circulation centralization, blood flow slowing, blood cells redistribution providing sufficient blood oxygenation. By the end of the first day we observed pronounced hemodilution, decreased blood oxygenation, blood flow restructuring with its acceleration above 1 ml/s, violation of tissue oxygenation, signs of hypovolemia. These changes were significantly different from group 2 and associated with circulatory decentralization with possible pulmonary microcirculation disturbances and interstitial edema. This processes contribute to disruption of tissue oxygenation. We assume that recurrent bleeding in group 2 was caused by fluid therapy in larger volumes than it was necessary in this clinical situation. CONCLUSION: Infusion therapy should be significantly reduced for the debut of gastroduodenal ulcerative bleeding. Sedative therapy is advisable to reduce the influence of central nervous system.


Asunto(s)
Fluidoterapia , Tracto Gastrointestinal/irrigación sanguínea , Hipoxia , Microcirculación/fisiología , Úlcera Péptica Hemorrágica , Úlcera Péptica , Adulto , Anciano , Manejo de la Enfermedad , Femenino , Fluidoterapia/efectos adversos , Fluidoterapia/métodos , Hemodinámica , Humanos , Hipoxia/diagnóstico , Hipoxia/etiología , Masculino , Persona de Mediana Edad , Úlcera Péptica/sangre , Úlcera Péptica/complicaciones , Úlcera Péptica/fisiopatología , Úlcera Péptica Hemorrágica/diagnóstico , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/terapia , Pronóstico , Recurrencia
3.
Gut ; 63(12): 1864-72, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24658598

RESUMEN

BACKGROUND: Patients with high Rockall scores have increased risk of ulcer rebleeding after 3-day esomeprazole infusions. OBJECTIVE: To investigate whether double oral esomeprazole given after a 3-day esomeprazole infusion decreases ulcer rebleeding for patients with high Rockall scores. DESIGN: We prospectively enrolled 293 patients with peptic ulcer bleeding who had achieved endoscopic haemostasis. After a 3-day esomeprazole infusion, patients with Rockall scores ≥6 were randomised into the oral double-dose group (n=93) or the oral standard-dose group (n=94) to receive 11 days of oral esomeprazole 40 mg twice daily or once daily, respectively. The patients with Rockall scores <6 served as controls (n=89); they received 11 days of oral esomeprazole 40 mg once daily. Thereafter, all patients received oral esomeprazole 40 mg once daily for two more weeks until the end of the 28-day study period. The primary end point was peptic ulcer rebleeding. RESULTS: Among patients with Rockall scores ≥6, the oral double-dose group had a higher cumulative rebleeding-free proportion than the oral standard-dose group (p=0.02, log-rank test). The proportion of patients free from recurrent bleeding during the 4th-28th day in the oral double-dose group remained lower than that of the group with Rockall scores <6 (p=0.03, log-rank test). Among patients with Rockall scores ≥6, the rebleeding rate was lower in the oral double-dose group than in the oral standard-dose group (4th-28th day: 10.8% vs 28.7%, p=0.002). CONCLUSIONS: Double oral esomeprazole at 40 mg twice daily after esomeprazole infusion reduced recurrent peptic ulcer bleeding in high-risk patients with Rockall scores ≥6. TRIAL REGISTRATION NUMBER: NCT01591083.


Asunto(s)
Úlcera Duodenal , Esomeprazol/administración & dosificación , Úlcera Péptica Hemorrágica , Prevención Secundaria , Úlcera Gástrica , Administración Oral , Adulto , Anciano , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Úlcera Duodenal/complicaciones , Úlcera Duodenal/diagnóstico , Úlcera Duodenal/fisiopatología , Femenino , Hemostasis Endoscópica/métodos , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/diagnóstico , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/terapia , Inhibidores de la Bomba de Protones/administración & dosificación , Índice de Severidad de la Enfermedad , Úlcera Gástrica/complicaciones , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/fisiopatología , Resultado del Tratamiento
4.
Digestion ; 89(3): 239-46, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24903331

RESUMEN

BACKGROUND: Bleeding peptic ulcer (BPU) frequently occurs in the absence of preceding dyspeptic symptoms. We have observed that patients with BPU had a diminished symptom response to nutrient challenge test compared to uncomplicated peptic ulcer disease (uPUD). We postulated that more symptoms are manifest in patients with uPUD than BPU because there are greater derangements in gastric motor function. AIM: To assess gastric emptying in patients with BPU, uPUD and healthy controls (HC). METHODS: We studied 17 patients with BPU, 10 with uPUD, and 15 HC. After an 8-hour fast, subjects ingested 200 ml of an enteral feeding solution, containing 5 MBq (99m)Tc-rhenium sulphide colloid, every 5 min up to a cumulative volume of 800 ml. Gastric emptying was measured by scintigraphy for the total, proximal and distal stomach. RESULTS: Patients with uPUD had significantly higher gastric retention in the proximal and total stomach at 100 min than HC and BPU, while BPU had similar percent retention to HC. Patients with uPUD had significantly higher cumulative symptom response to the nutrient challenge than did HC and BPU, while BPU had similar symptom responses to HC. CONCLUSIONS: Patients with uPUD have significantly delayed gastric emptying compared to HC and BPU. Data suggest that in addition to alterations of visceral sensory function, altered gastric motor function occurs during a nutrient challenge in uPUD but not BPU. Gastric motor function may contribute to the manifestation of dyspeptic symptoms in PUD.


Asunto(s)
Vaciamiento Gástrico , Úlcera Péptica Hemorrágica/diagnóstico , Anciano , Dispepsia/fisiopatología , Femenino , Vaciamiento Gástrico/fisiología , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/fisiopatología , Respuesta de Saciedad/fisiología , Encuestas y Cuestionarios , Vísceras/inervación
5.
Khirurgiia (Mosk) ; (2): 4-7, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-24736532

RESUMEN

It was done the retrospective analysis of the endoscopic hemostasis effectiveness in 207 patients with gastroduodenal bleeding in the period from November 2011 to April 2013. The differential approach to the choice of hemostasis methods and consistency of their application were developed. It was done the comparative analysis of two- and three-stages combined hemostasis results. The analysis included the infiltration of the submucosal layer by 0.01% solution of adrenaline, argon-plasma coagulation and hemostatic glue applique.


Asunto(s)
Coagulación con Plasma de Argón , Epinefrina/uso terapéutico , Hemostasis Endoscópica , Hemostáticos/uso terapéutico , Úlcera Péptica Hemorrágica , Coagulación con Plasma de Argón/efectos adversos , Coagulación con Plasma de Argón/métodos , Investigación sobre la Eficacia Comparativa , Femenino , Hemostasis Endoscópica/efectos adversos , Hemostasis Endoscópica/métodos , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica/complicaciones , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/cirugía , Estudios Retrospectivos , Prevención Secundaria , Índice de Severidad de la Enfermedad , Vasoconstrictores/uso terapéutico
6.
Khirurgiia (Mosk) ; (8): 23-7, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25327671

RESUMEN

It was analyzed the treatment results of 1341 patients with diagnosed ulcerative bleeding. The data shows that at present time mortality rate in case of ulcerative bleeding is determined by bleeding outcomes in patients with severe concomitant diseases including elderly patients. It was not observed significant advantages in any methods of endoscopic hemostasis for stop and prevention of recurrence ulcerative bleeding. All techniques are equivalent alternatives. None prognosis scale of recurrence ulcerative bleeding probability has high specificity and sensitivity.


Asunto(s)
Hemostasis Endoscópica , Úlcera Péptica Hemorrágica , Úlcera Péptica/complicaciones , Adulto , Anciano , Comorbilidad , Femenino , Hemostasis Endoscópica/efectos adversos , Hemostasis Endoscópica/métodos , Hemostasis Endoscópica/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/mortalidad , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/terapia , Pronóstico , Ajuste de Riesgo/métodos , Medición de Riesgo , Federación de Rusia/epidemiología , Prevención Secundaria , Índice de Severidad de la Enfermedad , Análisis de Supervivencia , Resultado del Tratamiento
7.
Klin Khir ; (7): 17-9, 2014 Jul.
Artículo en Ucraniano | MEDLINE | ID: mdl-25252405

RESUMEN

Examination of patients, suffering gastroduodenal ulcer, complicated by hemorrhage, was conducted, using clinical, microbiological, immunohistochemical methods and chromatomassspectrography. Enhanced activity of inducible NO-synthase, contamination of periulcer zone with microorganisms Klebsiella pneumoniae, Streptococcus beta-haemoliticus, enhancement of contents of catecholamines and serotonin in the blood serum were revealed. These changes are most expressed in severe blood loss, unstable local endoscopic hemostasis, high risk of a recurrent hemorrhage occurrence. The data obtained permit to prognosticate severity of a pathologic process course and to improve the treatment programe.


Asunto(s)
Sistema Endocrino/fisiopatología , Mucosa Gástrica/patología , Mucosa Intestinal/patología , Úlcera Péptica Hemorrágica/cirugía , Úlcera Péptica/cirugía , Catecolaminas/sangre , Endoscopía del Sistema Digestivo , Mucosa Gástrica/metabolismo , Mucosa Gástrica/microbiología , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Klebsiella pneumoniae/aislamiento & purificación , Óxido Nítrico Sintasa de Tipo II/metabolismo , Úlcera Péptica/sangre , Úlcera Péptica/patología , Úlcera Péptica/fisiopatología , Úlcera Péptica Hemorrágica/sangre , Úlcera Péptica Hemorrágica/patología , Úlcera Péptica Hemorrágica/fisiopatología , Serotonina/sangre , Índice de Severidad de la Enfermedad , Streptococcus/aislamiento & purificación
8.
9.
Gut ; 65(9): 1438, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26719301
10.
Dig Dis ; 29(5): 494-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22095017

RESUMEN

Peptic ulcer bleeding is one of the most common emergency situations in medicine. Combined pharmacological and endoscopic therapy together with emerging interventional radiological procedures are successfully treating peptic ulcer disease, reserving surgical procedures for only a small portion of patients unresponsive to 'conventional' therapy. Technological advancement has seen a great improvement in the field of endoscopic treatment in the form of various methods of hemostasis. However, pharmacological therapy with proton pump inhibitors still plays the central role in the peptic ulcer bleeding treatment algorithm.


Asunto(s)
Ácido Gástrico/metabolismo , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Inhibidores de la Bomba de Protones/uso terapéutico , Humanos , Úlcera Péptica/complicaciones , Úlcera Péptica Hemorrágica/epidemiología , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/fisiopatología
11.
Vestn Ross Akad Med Nauk ; (1): 29-35, 2011.
Artículo en Ruso | MEDLINE | ID: mdl-21395093

RESUMEN

The authors present results of examination and treatment of 698 patients with erosive-ulcerative lesions in the mucous membrane of the upper digestive tract that accounted for 39.49% of all subjects with gastrointestinal hemorrhage. These lesions were diagnosed in 73.8% of the patients in critical conditions. The leading role in their pathogenesis is played by ischemic-perfusion syndrome, gastric acid hypersecretion resulting in microcirculatory disorders, hypoxia, and activation of free radicals in gastric and duodenal mucosa. It is concluded that preventive and conservative therapy of the above lesions must be focused on the correction of ischemia and after-effects of reperfusion to achieve long-standing hypoacidic state (pH < 4) with the help of up-to-date antisecretory agents.


Asunto(s)
Antagonistas de los Receptores H2 de la Histamina/administración & dosificación , Úlcera Péptica Hemorrágica , Úlcera Péptica , Inhibidores de la Bomba de Protones/administración & dosificación , Daño por Reperfusión , Tracto Gastrointestinal Superior , Aclorhidria/inducido químicamente , Animales , Perros , Ácido Gástrico/metabolismo , Técnicas Hemostáticas , Antagonistas de los Receptores H2 de la Histamina/efectos adversos , Humanos , Modelos Animales , Membrana Mucosa/metabolismo , Membrana Mucosa/fisiopatología , Úlcera Péptica/tratamiento farmacológico , Úlcera Péptica/etiología , Úlcera Péptica/metabolismo , Úlcera Péptica/fisiopatología , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/terapia , Inhibidores de la Bomba de Protones/efectos adversos , Daño por Reperfusión/complicaciones , Daño por Reperfusión/metabolismo , Daño por Reperfusión/fisiopatología , Factores de Riesgo , Resultado del Tratamiento , Tracto Gastrointestinal Superior/metabolismo , Tracto Gastrointestinal Superior/fisiopatología
12.
Khirurgiia (Mosk) ; (7): 53-5, 2011.
Artículo en Ruso | MEDLINE | ID: mdl-21983535

RESUMEN

The study is based on the examination of 12 patients with perforative duodenal ulcer and 24 patients operated on recurrent bleeding duodenal ulcer. Some component of the immune system, such as T- and B-lymphocytes rates, immunoglobulin rate and macrophagal activity, were decreased prior the beginning of the complex treatment. Normalisation of humoral and cell immunity was registered on 10-12 days after the beginning of the ozone and low-intensive laser irradiation.


Asunto(s)
Úlcera Duodenal/complicaciones , Tracto Gastrointestinal/efectos de la radiación , Inmunidad/efectos de la radiación , Terapia por Luz de Baja Intensidad/métodos , Ozono/uso terapéutico , Úlcera Péptica Hemorrágica , Úlcera Péptica Perforada , Terapia Combinada , Monitoreo de Drogas , Tracto Gastrointestinal/irrigación sanguínea , Tracto Gastrointestinal/inmunología , Humanos , Sistema Inmunológico/efectos de la radiación , Infusiones Parenterales , Oxidantes Fotoquímicos/uso terapéutico , Úlcera Péptica Hemorrágica/inmunología , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/terapia , Úlcera Péptica Perforada/inmunología , Úlcera Péptica Perforada/fisiopatología , Úlcera Péptica Perforada/terapia , Recurrencia , Flujo Sanguíneo Regional/efectos de la radiación , Resultado del Tratamiento
13.
Khirurgiia (Mosk) ; (12): 64-70, 2011.
Artículo en Ruso | MEDLINE | ID: mdl-22433528

RESUMEN

The role of the free radical processes (FRP) is shown and objectified in the development of the ulcer gastro-intestinal bleedings (UGIB). It is revealed on the first day of hospitalization already. The greatest imbalance of the FRP is registered in heavy patients with acute UGIB. It appeared like decrease of the oxygen and activation of the lipid FRP disregulation. Unheavy patients have FRP changes refer to the oxygen part of the oxidation process only. Intensification FRP in process of increase of weight disease consists in decrease activity oxygen and increase a lipid disbalance. FRP disbalance has long time proceeds, last till the patient's discharge. Results of the research prove as much as possible early inclusion in a complex of medical actions antoixidant therapy. The high efficiency of the energetic corrector reamberin in a dose of 400-800 ml was shown in patients with UGIB.


Asunto(s)
Úlcera Duodenal , Radicales Libres/metabolismo , Meglumina/análogos & derivados , Úlcera Péptica Hemorrágica , Úlcera Gástrica , Succinatos , Antioxidantes/administración & dosificación , Antioxidantes/efectos adversos , Relación Dosis-Respuesta a Droga , Úlcera Duodenal/tratamiento farmacológico , Úlcera Duodenal/metabolismo , Úlcera Duodenal/fisiopatología , Femenino , Humanos , Infusiones Intravenosas , Peroxidación de Lípido/efectos de los fármacos , Masculino , Meglumina/administración & dosificación , Meglumina/efectos adversos , Persona de Mediana Edad , Oxidación-Reducción/efectos de los fármacos , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Úlcera Péptica Hemorrágica/metabolismo , Úlcera Péptica Hemorrágica/fisiopatología , Índice de Severidad de la Enfermedad , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/metabolismo , Úlcera Gástrica/fisiopatología , Succinatos/administración & dosificación , Succinatos/efectos adversos , Resultado del Tratamiento
14.
J Gastroenterol Hepatol ; 25(6): 1162-9, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20594234

RESUMEN

BACKGROUND AND AIMS: Peptic ulcer disease (PUD) usually manifests as either dyspepsia or less commonly with complications such as bleeding. Patients with bleeding ulcers are often asymptomatic until the bleeding occurs. A lack of dyspeptic symptoms might be explained by impaired visceral sensory function. The aim of this study was to assess symptom profiles and compare visceral sensory thresholds in patients with bleeding peptic ulcer (BPU) and uncomplicated PUD. METHODS: A total of 30 patients with BPU, 25 with uncomplicated PUD and 32 healthy controls (HC) without dyspeptic symptoms were recruited. In ulcer patients after at least 8 weeks of ulcer treatment and an 8-hr fast, visceral sensitivity was tested using a standardized nutrient challenge with an enteral feeding solution. Five key symptoms (fullness, abdominal pain, retrosternal/abdominal burning, nausea, and regurgitation) were assessed using visual analog scales (0-100). RESULTS: Twenty-five of the 30 (83%, 95% confidence interval 65-94%) patients with BPU had no dyspeptic symptoms compared with none of the 25 uncomplicated PUD patients. Patients with BPU and HC had significantly lower symptom responses (BPU 127.6 +/- 24.6, HC 89.8 +/- 13.9) to the nutrient challenge than uncomplicated PUD patients (338.4 +/- 56.2, P < 0.0001). Patients with dyspeptic symptoms (30/55) had significantly higher symptom responses (327.3 +/- 47.8) than the 25/55 patients without symptoms (98.9 +/- 23.4, P < 0.0001). CONCLUSION: Most patients with BPU present without dyspeptic symptoms. Even after healing of the ulcer, patients with uncomplicated PUD have a significantly augmented symptom response to a standardized nutrient challenge compared to patients with complicated ulcers and HC. Differences in the processing of upper gastrointestinal visceral afferents may play a major role in the clinical presentation (complicated vs uncomplicated) of PUD.


Asunto(s)
Úlcera Duodenal/complicaciones , Dispepsia/etiología , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica/complicaciones , Enfermedades del Sistema Nervioso Periférico/etiología , Úlcera Gástrica/complicaciones , Aferentes Viscerales/fisiopatología , Úlcera Duodenal/diagnóstico , Úlcera Duodenal/fisiopatología , Dispepsia/diagnóstico , Dispepsia/fisiopatología , Endoscopía Gastrointestinal , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica/diagnóstico , Úlcera Péptica/fisiopatología , Úlcera Péptica Hemorrágica/diagnóstico , Úlcera Péptica Hemorrágica/fisiopatología , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Umbral Sensorial/fisiología , Índice de Severidad de la Enfermedad , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/fisiopatología
15.
Khirurgiia (Mosk) ; (8): 48-53, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-20823821

RESUMEN

The aim of the work was analysis of treatment of 560 patients with a gastrointestinal bleeding from acute ulcers. For estimation of patients was used universal integrated scale APACHE III. Tactics of treatment depend on secretory functions of a stomach and group of polyorganical difunction. At 428 (76,5%) patients with acute ulcers on the background increase secretion of stomach was treatment antysecretion therapy. At 132 (23,5%) patients with acute ulcers on the background of normal ore decrease secretion of stomach was treatment Cytoflavin - the metabolic preparation possessing antyoxidation, cytoprotection and immunomodulaytion activity. For studying antyoxidation and antihypoxation actions of Cytoflavin estimated of microcirculation mucous of a stomach with the laser Doppler floymetrya before course of treatment, observed increase of index efficiency of microcirculation and increase a blood-groove in a stomach at patients with acute peptic ulcers on a background of treatment of Cytoflavin. After course of treatment of Cytoflavin decrease in points on system APACHE III on 5,5-25% at all patients that has led to decrease mortality on 20% in this group of patients.


Asunto(s)
Úlcera Duodenal/tratamiento farmacológico , Mononucleótido de Flavina/uso terapéutico , Inosina Difosfato/uso terapéutico , Niacinamida/uso terapéutico , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Úlcera Gástrica/tratamiento farmacológico , Succinatos/uso terapéutico , APACHE , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Animales , Combinación de Medicamentos , Úlcera Duodenal/mortalidad , Úlcera Duodenal/fisiopatología , Femenino , Mucosa Gástrica/irrigación sanguínea , Humanos , Flujometría por Láser-Doppler , Masculino , Microcirculación , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/mortalidad , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Gástrica/mortalidad , Úlcera Gástrica/fisiopatología , Adulto Joven
16.
Klin Med (Mosk) ; 87(5): 47-52, 2009.
Artículo en Ruso | MEDLINE | ID: mdl-19565828

RESUMEN

65 patients with hypertensive disease (HD) and without it were examined in the acute period of gastroduodenal ulcer hemorrhage (UH) by 24 hour ECG monitoring, measurement of arterial pressure (AP), and evaluation of the severity of psychovegetative syndrome. Control groups comprised 20 patients with ulcer disease (UD), 28 with HD, and 12 with UD + HD. Patients of the latter group, similar to normotensive ones, suffered suppressed function of the sinus node in addition to functional changes in myocardium including a change of ST-T segment. Circadian rhythm of AD was unrelated to the presence and absence of HD. In both cases, blood loss was associated with anxiety-depressive condition and well-apparent ergotropic reactions. Patients with UD and HD had more expressed emotional and personality disorders associated with impaired vegetative response. Dippers had marked sympathetic activity at rest and in vegetative reactivity tests whereas non-dippers showed ergotropic effects in similar tests.


Asunto(s)
Monitoreo Ambulatorio de la Presión Arterial/métodos , Presión Sanguínea/fisiología , Ritmo Circadiano/fisiología , Frecuencia Cardíaca/fisiología , Hipertensión/fisiopatología , Úlcera Péptica Hemorrágica/fisiopatología , Trastornos Psicóticos/complicaciones , Enfermedad Aguda , Úlcera Duodenal/complicaciones , Úlcera Duodenal/fisiopatología , Electrocardiografía Ambulatoria , Estudios de Seguimiento , Humanos , Hipertensión/complicaciones , Úlcera Péptica Hemorrágica/complicaciones , Pronóstico , Trastornos Psicóticos/fisiopatología , Úlcera Gástrica/complicaciones , Úlcera Gástrica/fisiopatología
18.
J Physiol Pharmacol ; 58 Suppl 6: 53-64, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18212400

RESUMEN

Stress that appears as a consequence of burns, surgical trauma and life threatening conditions is a serious clinical entity, can result in acute gastric mucosal lesions. Such stress lesions can develop in response to the imbalance between the aggressive factors promoting mucosal damage and the gastric mucosal defense mechanisms including predominantly gastric blood flow (GBF), biosynthesis of gastroprotective prostaglandins (PG) and enhanced mucus/bicarbonate secretion. Melatonin, a major hormone of pineal gland, whose activity is also abundant in the gastrointestinal tract, was shown to inhibit gastric acid secretion, augment GBF and scavenge free radicals, resulting in the attenuation of stress-induced gastric lesions. Melatonin is released during the night but little is known about the effect of circadian rhythm and day/night alterations in melatonin secretion on the formation of stress-induced gastric lesions. Using rats with intact pineal glands and those with removed pineal glands (pinealectomy) exposed to water immersion and restraint stress (WRS) at both, day and night hours, we studied the effect of light and nocturnal melatonin on the formation of these lesions, and accompanying changes in GBF and plasma melatonin levels. It was found that the gastric mucosa exposed to WRS of various time duration's lasting 1.5, 3 and 6 h, time-dependently increased the number of gastric lesions and this effect was accompanied by the time-dependent fall in the GBF and an increase in the plasma and luminal melatonin levels. Pinealectomy augmented WRS-induced lesions at each time intervals of WRS and produced a marked fall in the GBF and plasma and luminal melatonin levels at each time interval of WRS tested. WRS lesions were significantly reduced at night hours and showed circadian variations in plasma levels melatonin with significantly higher plasma melatonin levels at night than in the day and with a greater magnitude of damage induced in the daily hours than at night hours. WRS-induced gastric mucosal lesions were markedly enhanced in pinealectomized rats, both at day and night, and this was accompanied by a significant fall in plasma melatonin levels Stress that appears as a consequence of burns, surgical trauma and life threatening conditions is a serious clinical entity, can result in acute gastric mucosal lesions. Such stress lesions can develop in response to the imbalance between the aggressive factors promoting mucosal damage and the gastric mucosal defense mechanisms including predominantly gastric blood flow (GBF), biosynthesis of gastroprotective prostaglandins (PG) and enhanced mucus/bicarbonate secretion. Melatonin, a major hormone of pineal gland, whose activity is also abundant in the gastrointestinal tract, was shown to inhibit gastric acid secretion, augment GBF and scavenge free radicals, resulting in the attenuation of stress-induced gastric lesions. Melatonin is released during the night but little is known about the effect of circadian rhythm and day/night alterations in melatonin secretion on the formation of stress-induced gastric lesions. Using rats with intact pineal glands and those with removed pineal glands (pinealectomy) exposed to water immersion and restraint stress (WRS) at both, day and night hours, we studied the effect of light and nocturnal melatonin on the formation of these lesions, and accompanying changes in GBF and plasma melatonin levels. It was found that the gastric mucosa exposed to WRS of various time duration's lasting 1.5, 3 and 6 h, time-dependently increased the number of gastric lesions and this effect was accompanied by the time-dependent fall in the GBF and an increase in the plasma and luminal melatonin levels. Pinealectomy augmented WRS-induced lesions at each time intervals of WRS and produced a marked fall in the GBF and plasma and luminal melatonin levels at each time interval of WRS tested. WRS lesions were significantly reduced at night hours and showed circadian variations in plasma levels melatonin with significantly higher plasma melatonin levels at night than in the day and with a greater magnitude of damage induced in the daily hours than at night hours. WRS-induced gastric mucosal lesions were markedly enhanced in pinealectomized rats, both at day and night, and this was accompanied by a significant fall in plasma melatonin levels with a pronounced reduction in mucosal generation of PGE(2) and GBF and by a small increase in plasma melatonin levels during the dark phase. We conclude that 1) stress-induced gastric bleeding erosions exhibit circadian rhythm with an increase in the day and attenuation at night and that these fluctuations in the formation of stress-induced gastric damage may depend upon the melatonin synthesis 2) the progressive increase in plasma melatonin in pinealectomized animals exposed to various time intervals of WRS suggests that extra-pineal melatonin possibly that derived from gastrointestinal tract, play an important role in the gastric mucosal defense against stress-induced gastric damage.


Asunto(s)
Ritmo Circadiano/fisiología , Melatonina/sangre , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Gástrica/fisiopatología , Estrés Psicológico/complicaciones , Enfermedad Aguda , Animales , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/irrigación sanguínea , Mucosa Gástrica/efectos de los fármacos , Masculino , Melatonina/metabolismo , Melatonina/farmacología , Úlcera Péptica Hemorrágica/etiología , Úlcera Péptica Hemorrágica/metabolismo , Glándula Pineal/fisiopatología , Radioinmunoensayo , Ratas , Ratas Sprague-Dawley , Restricción Física , Úlcera Gástrica/etiología , Úlcera Gástrica/metabolismo
19.
Dig Liver Dis ; 38(2): 143-8, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16005698

RESUMEN

Peptic ulcer bleeding remains a common medical emergency and despite recent advances in management is still associated with high mortality. Endoscopic treatment remains the cornerstone for the effective management of high-risk patients. Recent evidence suggests that potent antisecretory drugs that inhibit gastric acid secretion, such as proton pump inhibitors, may be of help alone or in combination with endotherapy in the management of peptic ulcer bleeding. Somatostatin appears to offer a distinct advantage over antisecretory drugs, as it inhibits both acid and pepsin secretion and combines these effects with a reduction in gastroduodenal mucosal blood flow which seems to be important in the pathophysiology of peptic ulcer bleeding. Additionally, the inhibition of pepsin secretion might induce a decreased proteolytic activity preventing the dissolution of freshly formed clots at the site of bleeding. Despite its theoretical advantages, there has been very little evidence in the recent past in setting of randomised, controlled, clinical trials. In reviewing the available data, we found that the efficacy of somatostatin and its analogue octreotide are different in the control of peptic ulcer bleeding and this might be due to the different distribution of its receptors through the GI tract. Further studies are needed to define the exact role, if any, of somatostatin and its analogues, in high-risk patients with peptic ulcer bleeding and this might be a rather interesting area for future research.


Asunto(s)
Fármacos Gastrointestinales/uso terapéutico , Hormonas/uso terapéutico , Octreótido/uso terapéutico , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Somatostatina/uso terapéutico , Humanos , Úlcera Péptica Hemorrágica/fisiopatología , Ensayos Clínicos Controlados Aleatorios como Asunto , Somatostatina/análogos & derivados , Somatostatina/farmacología , Circulación Esplácnica/efectos de los fármacos
20.
World J Gastroenterol ; 12(19): 3108-13, 2006 May 21.
Artículo en Inglés | MEDLINE | ID: mdl-16718798

RESUMEN

AIM: To define the optimal injection volume of epinephrine with high efficacy for hemostasis and low complication rate in patients with actively bleeding ulcers. METHODS: This prospective, randomized, comparative trial was conducted in a medical center. A total of 228 patients with actively bleeding ulcers (spurting or oozing) were randomly assigned to three groups with 20, 30 and 40 mL endoscopic injections of an 1:10000 solution of epinephrine. The hemostatic effects and clinical outcomes were compared between the three groups. RESULTS: There were no significant differences in all background variables between the three groups. Initial hemostasis was achieved in 97.4%, 98.7% and 100% of patients respectively in the 20, 30 and 40 mL epinephrine groups. There were no significant differences in the rate of initial hemostasis between the three groups. The rate of peptic ulcer perforation was significantly higher in the 40 mL epinephrine group than in the 20 and 30 mL epinephrine groups (P < 0.05). The rate of recurrent bleeding was significantly higher in the 20 mL epinephrine group (20.3%) than in the 30 (5.3%) and 40 mL (2.8%) epinephrine groups (P < 0.01). There were no significant differences in the rates of surgical intervention, the amount of transfusion requirements, the days of hospitalization, the deaths from bleeding and 30 d mortality between the three groups. The number of patients who developed epigastric pain due to endoscopic injection, was significantly higher in the 40 mL epinephrine group (51/76) than in the 20 (2/76) and 30 mL (5/76) epinephrine groups (P < 0.001). Significant elevation of systolic blood pressure after endoscopic injection was observed in the 40 mL epinephrine group (P < 0.01). Significant decreasing and normalization of pulse rates after endoscopic injections were observed in the 20 mL and 30 mL epinephrine groups (P < 0.01). CONCLUSION: Injection of 30 mL diluted epinephrine (1:10000) can effectively prevent recurrent bleeding with a low rate of complications. The optimal injection volume of epinephrine for endoscopic treatment of an actively bleeding ulcer (spurting or oozing) is 30 mL.


Asunto(s)
Epinefrina/administración & dosificación , Epinefrina/uso terapéutico , Inyecciones/normas , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Vasoconstrictores/administración & dosificación , Vasoconstrictores/uso terapéutico , Anciano , Presión Sanguínea/fisiología , Endoscopía Gastrointestinal , Epinefrina/efectos adversos , Femenino , Hemostasis/fisiología , Humanos , Inyecciones/métodos , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/fisiopatología , Úlcera Péptica Hemorrágica/prevención & control , Estudios Prospectivos , Recurrencia , Vasoconstrictores/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA